News

The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.
Cologuard Classic will "make a couple tweaks to make the fan experience even better, but I think we have some good bones in place for the next three years" at hard-walking La Paloma Country Club.
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...
An Alabama family has filed a high-profile lawsuit in Shelby County Circuit Court, alleging that a life-altering medical failure led to a missed diagnosis of advanced, incurable colon cancer. The ...
Zacks Investment Research on MSN4d
Tempus AI Taps Growing ICI Market With New xM Assay
Tempus AI, Inc. TEM recently introduced xM for treatment response monitoring (TRM), a liquid biopsy assay. It is designed to detect molecular response to immune-checkpoint inhibitor (ICI) therapy in ...
University research in Wisconsin led to $500 million Third Wave business, screening tests for cancer, including Cologuard ...
The Escape Pod’s Lil Jon remix is Campaign of the Year, Health Care, Gold, in the 2025 Small Agency Awards.
Easy at-home tests for colon cancer, including FIT and Cologuard, offer alternatives to traditional colonoscopies for early ...
When It Comes to Colon Cancer Screening, Early Detection Is Key The Cologuard® test screens for the most preventable but least prevented cancer.
Exact Sciences reports strong Q1 2025 results with 11% revenue growth, boosted by Cologuard Plus and Oncodetect.
The Cologuard Plus test is expected to reduce false positives by more than 40% compared to the original Cologuard test, helping minimize unnecessary follow-up colonoscopies.